Plumbagin Mediates Cardioprotection Against Myocardial Ischemia/Reperfusion Injury Through Nrf-2 Signaling-Reference-Cited by-同舟云学术

Plumbagin Mediates Cardioprotection Against Myocardial Ischemia/Reperfusion Injury Through Nrf-2 Signaling

Published:2016-04-14 Issue: Volume:22 Page:1250-1257
ISSN:1643-3750
Container-title:Medical Science Monitor
language:en
Short-container-title:Med Sci Monit

Author:

Wang Shi-Xun¹,Wang Jian¹,Shao Jing-Bo¹,Tang Wei-ning¹,Zhong Jing-Quan²

Affiliation:

1. Department of Cardiology, Weifang People’s Hospital, Weifang, Shandong, China (mainland)

2. Key Laboratory of Cardiovascular Remodeling and Function Research, Chinese Ministry of Education and Chinese Ministry of Health, Department of Cardiology, Qilu Hospital of Shandong University, Jinan, Shandong, China (mainland)

Publisher

International Scientific Information, Inc.

Subject

General Medicine

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacological Features and Therapeutic Implications of Plumbagin in Cancer and Metabolic Disorders: A Narrative Review;Nutrients;2024-09-08

2. Fluorescent probe for evaluating the preventive utility of plumbagin in ischemia–reperfusion injury;Journal of Photochemistry and Photobiology A: Chemistry;2024-09

3. Plumbagin ameliorates LPS‐induced acute lung injury by regulating PI3K/AKT/mTOR and Keap1‐Nrf2/HO‐1 signalling pathways;Journal of Cellular and Molecular Medicine;2024-07

4. Potential Targets of Natural Products for Improving Cardiac Ischemic Injury: The Role of Nrf2 Signaling Transduction;Molecules;2024-04-26

5. Unravelling the potent anti-oxidant and anti-inflammatory actions of plumbagin: A review of preclinical discoveries;Pharmacological Research - Modern Chinese Medicine;2024-03